C
Citius Oncology Inc
NASDAQ:CTOR
Citius Oncology Inc
NASDAQ:CTOR
Price:
1.08
USD
1.89%
Market Closed
Market Cap:
$90.2m
Cash Flow Statement
Cash Flow Statement
Citius Oncology Inc
Citius Oncology Inc
Currency: USD
| Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|
| Operating Cash Flow | |||||
| Net Income |
(28)
|
(26)
|
(42)
|
(25)
|
|
| Change in Deffered Taxes |
1
|
1
|
1
|
1
|
|
| Stock-Based Compensation |
15
|
13
|
14
|
8
|
|
| Other Non-Cash Items |
9
|
8
|
15
|
8
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
18
|
18
|
26
|
10
|
|
| Cash from Operating Activities |
0
N/A
|
0
N/A
|
1
+429%
|
(5)
N/A
|
|
| Investing Cash Flow | |||||
| Other Items |
0
|
0
|
0
|
(6)
|
|
| Cash from Investing Activities |
0
N/A
|
0
N/A
|
0
N/A
|
(6)
N/A
|
|
| Financing Cash Flow | |||||
| Net Issuance of Common Stock |
0
|
0
|
0
|
15
|
|
| Cash from Financing Activities |
0
N/A
|
0
N/A
|
0
N/A
|
15
N/A
|
|
| Change in Cash | |||||
| Net Change in Cash |
0
N/A
|
0
N/A
|
0
N/A
|
4
+11 976%
|
|
| Free Cash Flow | |||||
| Free Cash Flow |
0
N/A
|
0
N/A
|
1
+429%
|
(5)
N/A
|
|
Switch to:
Switch to:
See Also
Discover More
